PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
20.29%
Revenue growth 1.25-1.5x VET's 18.33%. Bruce Berkowitz would examine if growth advantage is sustainable.
25.42%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
15.01%
Gross profit growth below 50% of VET's 61.35%. Michael Burry would check for structural issues.
-4.39%
Margin decline while VET shows 36.36% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
318.18%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
157.14%
Other expenses growth above 1.5x VET's 20.11%. Michael Burry would check for concerning trends.
128.13%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
50.92%
Total costs growth while VET reduces costs. John Neff would investigate differences.
-5.43%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-21.70%
Both companies reducing D&A. Martin Whitman would check industry patterns.
465.75%
Similar EBITDA growth to VET's 618.99%. Walter Schloss would investigate industry trends.
-44.15%
EBITDA margin decline while VET shows 20.16% growth. Joel Greenblatt would examine position.
132.99%
Operating income growth below 50% of VET's 426.56%. Michael Burry would check for structural issues.
127.43%
Operating margin growth below 50% of VET's 375.98%. Michael Burry would check for structural issues.
-21.57%
Other expenses reduction while VET shows 419.59% growth. Joel Greenblatt would examine advantage.
120.72%
Pre-tax income growth below 50% of VET's 1386.11%. Michael Burry would check for structural issues.
117.22%
Pre-tax margin growth below 50% of VET's 1186.90%. Michael Burry would check for structural issues.
-528.57%
Tax expense reduction while VET shows 3006.58% growth. Joel Greenblatt would examine advantage.
150.33%
Net income growth below 50% of VET's 966.38%. Michael Burry would check for structural issues.
141.84%
Net margin growth below 50% of VET's 832.19%. Michael Burry would check for structural issues.
150.21%
EPS growth below 50% of VET's 975.00%. Michael Burry would check for structural issues.
149.15%
Diluted EPS growth below 50% of VET's 961.11%. Michael Burry would check for structural issues.
0.40%
Share count change of 0.40% while VET is stable. Bruce Berkowitz would verify approach.
2.39%
Diluted share change of 2.39% while VET is stable. Bruce Berkowitz would verify approach.